Developer of industrial cleaning laser systems Laser Photonics Corporation (LPC) has signed a definitive agreement to acquire Control Micro Systems, Inc. (CMS), a provider of laser solutions for the pharmaceutical industry. The acquisition of CMS' assets, in a deal worth $1.05 million, is expected to provide an opportunity for Laser Photonics to strategically broaden its market reach, engineering talent, and technology portfolio for the medical and pharmaceuticals industries. Control Micro Systems’ (CMS') laser drilling system used in controlled-release tablet production and packaging compliance. Courtesy of Laser Photonics Corporation. CMS delivers precision laser solutions to the pharmaceutical industry, particularly for controlled-release tablet production and packaging compliance. Its laser drilling systems are used to create microscopic apertures in tablets, allowing for precise control over drug release rates. This technology is essential for the manufacturing of medications that require gradual, timed release of active ingredients, ensuring improved patient adherence and therapeutic effectiveness. According to LPC CEO Wayne Tupuola, the acquisition expands LPC's reach into the growing pharmaceutical and medical manufacturing sector, a recession resistant market with significant barriers to entry, while diversifying the company's business. “We believe CMS is under-valued due to its lack of investment in sales and marketing over the past few years that will benefit from leveraging LPC’s existing sales and marketing infrastructure,” Tupuola said. He also stated that LPS will retain CMS’s existing workforce. *This story has been updated to indicate the acquisition value.